Drug Shortage Report for DUREZOL
Report ID | 59387 |
Drug Identification Number | 02415534 |
Brand name | DUREZOL |
Common or Proper name | DUREZOL .05% EMUL 5ML TRD |
Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | Difluprednate |
Strength(s) | 0.05% |
Dosage form(s) | EMULSION |
Route of administration | OPHTHALMIC |
Packaging size | 5ML |
ATC code | S01BA |
ATC description | ANTIINFLAMMATORY AGENTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2018-09-10 |
Actual start date | 2018-09-19 |
Estimated end date | 2018-10-05 |
Actual end date | 2018-09-27 |
Shortage status | Resolved |
Updated date | 2018-10-04 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-08-28 | English | Compare |
v2 | 2018-08-28 | English | Compare |
v3 | 2018-08-28 | French | Compare |
v4 | 2018-09-11 | English | Compare |
v5 | 2018-09-26 | English | Compare |
v6 | 2018-09-26 | French | Compare |
v7 | 2018-10-04 | English | Compare |
v8 | 2018-10-04 | French | Compare |
Showing 1 to 8 of 8